Bifidobacterium as a Delivery System of Functional Genes for Cancer Gene Therapy

Emerging Cancer Therapy: Microbial Approaches and Biotechnological Tools

Volumn , Issue , 2010, Pages 99-117

  Fu, Geng Feng ^a   Yin, Yan ^b   Hu, Bi ^b   Xu, Gen Xing ^b,c  

^a JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NANJING UNIVERSITY   (China)

^c Jiangsu Research Center for Gene Pharmaceutical Engineering and Technology   (China)

Author keywords

Bifidobacterium, as delivery system of functional genes for cancer gene therapy; Bifidobacterium, good vector for oral cancer gene therapy; Strategies for enzyme prodrug cancer therapy

Indexed keywords

EID: 84862956633     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470626528.ch5     Document Type: Chapter

References (59)

1. Klun A. , Mercenier A. , and Arigoni F. 2005 . Lemons from the genomes of Bifi dobacteria . FEMS Microbiol. Rev. 29: 491-509 .
2. Mckay L.L. , Baldwin K.A. , and Zottola E.A. 1972 . Loss of lactose metabolism in lactic streptococci . Appl. Environ. Microbiol. 23: 1090-1096 .
3. Sgorbati B. , Scardovi V. , and Leblanc D.J. 1982 . Plasmids in the genus Bifi dobacterium . J. Gen. Microbiol. 128: 2121-2131 .
4. Rossi M. , Brigidi P. , Gonzalez Vara y Rodriguez A. , and Matteuzzi D. 1996 . Characterization of the plasmid pMB1 from Bifi dobacterium longum and its use for shuttle vector construction . Res. Microbiol. 147: 133-143 .
5. Park M.S. , Shin D.W. , Lee K.H. , and Ji G.E. 1999 . Sequence analysis of plasmid pKJ50 from Bifi dobacterium longum . Microbiology. 145: 585-592 .
6. Corneau N. , Émond E. , and LaPointe G. 2004 . Molecular characterization of three plasmids from Bifi dobacterium longum . Plasmid. 51: 87-100 .
7. Park Y.S. , Kim K.H. , Park J.H. , Oh I.K. , and Yoon S.S. 2008 . Isolation and molecular characterization of a cryptic plasmid from Bifi dobacterium longum . Biotechnol. Lett. 30: 145-151 .
8. Lee J.H. , and O'Sullivan D.J. 2006 . Sequence analysis of two cryptic plasmids from Bifi dobacterium longum DJO10A and construction of a shuttle cloning vector . Appl. Environ. Microbiol. 72: 527-535 .
9. Guglielmetti S. , Karp M. , Mora D. , Tamagnini I. , and Parini C. 2007 . Molecular characterization of Bifi dobacterium longum biovar longum NAL8 plasmids and construction of a novel replicon screening system . Appl. Microbiol. Biotechnol. 74: 1053-1061 .
10. Mattarelli P. , Biavati B. , Alessandrini A. , Crociani F. , and Scardovi V. 1994 . Characterization of the plasmid pVS809 from Bifi dobacterium globosum . Microbiology. 17: 327-331 .
11. O'Riordan K. , and Fitzgerald G.F. 1999 . Molecular characterisation of a 5.75-kb cryptic plasmid from Bifi dobacterium breve NCFB2258 and determination of a mode of replication . FEMS Microbiol. Lett. 174: 285-294 .
12. Sgorbati B. , Scardovi V. , and LeBlanc D.J. 1982 . Plasmids in the genus Bifi dobacterium . J. Gen. Microbiol. 128: 2121-2131 .
13. Alvarez-Martín P. , Florez A.B. , and Mayo B. 2007 . Screening for plasmids among human bifi dobacteria species: sequencing and analysis of pBC1 from Bifi dobacterium catenulatum L48 . Plasmid. 57: 165-174 .
14. Sangrador-Vegas A. , Stanton C. , van Sinderen D. , Fitzgerald G.F. , and Ross R.P. 2007 . Characterisation of plasmid pASV479 from Bifi dobacterium pseudolongum subsp. globosum and its use for expression vector construction . Plasmid. 58: 140-147 .
15. Shkoporov A.N. , Efimov B.A. , Khokhlova E.V. , Steele J.L. , Kafarskaia L.I. , and Smeianov V.V. 2008 . Characterization of plasmids from human infant Bifi dobacterium strains: sequence analysis and construction of E. coli-Bifi dobacterium shuttle vectors . Plasmid. 60: 136-148 .
16. Rossi M. , Brigidi P. , and Matteuzzi D. 1997 . An effi cient transformation system for Bifi dobacterium spp . Lett. Appl. Microbiol. 24: 33-36 .
17. Vaupel P.W. 1993 . Oxygenation of solid tumors in drug resistance in oncology . In: Teicher B.A. , ed., Drug Resistance in Oncology . New York: Marcel Dekker , pp. 53-85 .
18. Yazawa K. , Fujimori M. , Amano J. , Kano Y. , and Taniguchi S. 2000 . Bifi dobacterium longum as a delivery system for cancer gene therapy: selective location and growth in hypoxic tumors . Cancer Gene Ther. 7: 269-274 .
19. Kimura N.T. , Taniguchi S. , and Aoki K. 1980 . Selective localization and growth of Bifi dobacterium bifi dum in mouse tumors following intravenous administration . Cancer Res. 40: 2061-2068 .
20. Yazawa K. , Fujimori M. , Nakamura T. , Sasaki T. , Amano J. , Kano Y. , and Taniguchi S. 2001 . Bifi dobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors . Breast Cancer Res. Treat. 66: 165-170 .
21. Nakamura T. , Sasaki T. , Fujimori M. , Yazawa K. , Kano Y. , Amano J. , and Taniguchi S. 2002 . Cloned cytosine deaminase gene expression of Bifi dobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors . Biosci. Biotechnol. Biochem. 66: 2362-2366 .
22. Sasaki T. , Fujimori M. , Hamaji Y. , Amano J. , and Taniguchi S. 2006 . Genetically engineered Bifi dobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats . Cancer Sci. 97: 649-657 .
23. Yi C. , Huang Y. , Guo Z. , and Wang S. 2005 . Construction of Bifi dobacterium infantis/ CD targeting gene therapy system . Chinese-German J. Clin. Oncol. 4: 244-247 .
24. Yi C. , Huang Y. , Guo Z.Y. , and Wang S.R. 2005 . Antitumor effect of cytosine deaminase/5- fl uorocytosine suicide gene therapy system mediated by Bifi dobacterium infantis on melanoma . Acta Pharmacol. Sin. 26: 629-634 .
25. Li X. , Fu G.F. , Fan Y.R. , Liu W.H. , Liu X.J. , Wang J.J. , and Xu G.X. 2003 . Bifi dobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth . Cancer Gene Ther. 10: 105-111 .
26. Fu G.F. , Li X. , Hou Y.Y. , Fan Y.R. , Liu W.H. , and Xu G.X. 2005 . Bifi dobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer . Cancer Gene Ther. 12: 133-140 .
27. Xu Y.F. , Zhu L.P. , Hu B. , Fu G.F. , Zhang H.Y. , Wang J.J. , and Xu G.X. 2007 . A new expression plasmid in Bifi dobacterium longum as a delivery system of endostatin for cancer gene therapy . Cancer Gene Ther. 14: 151-157 .
28. Park M.S. , Kwon B. , Shim J.J. , Huh C.S. , and Ji G.E. 2008 . Heterologous expression of cholesterol oxidase in Bifi dobacterium longum under the control of 16S rRNA gene promoter of bifi dobacteria . Biotechnol. Lett. 30: 165-172 .
29. Reyes Escogido M.L. , De Leon Rodriguez A. , and Barba de la Rosa A.P. 2007 . A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifi dobacterium longum . Biotechnol. Lett. 29: 1249-1253 .
30. Guglielmetti S. , Ciranna A. , Mora D. , Parini C. , and Karp M. 2008 . Construction, characterization and exemplifi cative application of bioluminescent Bifi dobacterium longum biovar longum . Int. J. Food Microbiol. 124: 285-290 .
31. Singh J. , Rivenson A. , Tomita M. , Shimamura S. , Ishibashi N. , and Reddy B.S. 1997 . Bifi dobacterium longum , a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis . Carcinogenesis. 18: 833-841 .
32. Leng S. , and Wang R. 2005 . Experimental study on antitumor effect with Bifi dobacterium and its broth . Chin. J. Microecol. 17: 411-414 .
33. Kohwi Y. , Imai K. , Tamura Z. , and Hashimoto Y. 1978 . Antitumor effect of Bifi dobaterium infants in mice . Gann. 69: 613-618 .
34. Liu R.Z. , and Zhang L.Z. 2001 . Study on immune mechanism in anticancer of Bifi dobacterium . Chin. J. Cancer Biother. 8: 44-45
35. Sekine K. , Ohta J. , Onishi M. , Tatsuki T. , Shimokawa Y. , Toida T. , Kawashima T. , and Hashimoto Y. 1995 . Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifi dobacterium infantis . Biol. Pharm. Bull. 18: 148-153 .
36. Takahashi N. , Kitazawa H. , Iwabuchi N. , Xiao J.Z. , Miyaji K. , Iwatsuki K. , and Saito T. 2006 . Oral administration of an immunostimulatory DNA sequence from Bifi dobacterium longum improves Th1/Th2 balance in murine model . Biosci. Biotechnol. Biochem. 70: 2013-2017 .
37. Kubota Y. 1990 . Fecal intestinal fl ora in patients with colon adenoma and colon cancer . Nippon Shokakibyo Gakkai Zasshi. 87: 771-779 .
38. Cai L.Z. , Li S.J. , and Guan C.N. 2005 . In vitro and in vivo antitumor effects of whole peptidoglycan from Bifi dobacterium on colon carcinoma . J. Guangdong Med. Coll. 23: 500-502 .
39. Goldin B.R. , Adlercreutz H. , Dwyer J.T. , Swenson L. , Warram J.H. , and Gorbach S.L. 1980 . Effect of diet on Lactobacillus acidophilus supplements on human fecal bacterial enzymes . J. Natl. Cancer Inst. 64: 255-260 .
40. Bianco R. , Melisi D. , Ciardiello F. , and Tortora G. 2006 . Key cancer cell signal transduction pathways as therapeutic targets . Eur. J. Cancer. 42: 290-294 .
41. Yarden Y. , and Sliwkowski M.X. 2001 . Untangling the ErbB signaling network . Nat. Rev. Mol. Cell Biol. 2: 127-137 .
42. Li Y. , and Wang L. 2006 . Study on anticancer signal mechanism of Bifi dobacterium . Chin. J. Microecol. 18: 497-498 .
43. Tang L. , Ran F. , and Zhao B. 1998 . Effect of Bifi dobacterium longum on cAMP, cGMA in colon cancer cell lines . Chin. J. Microecol. 10: 257-259 .
44. Tang L. , Zhang Y. , and Zhao B. 2000 . Regulatory effect of Bifi dobaterium on DAG in human colon cancer cells . Chin. J. Microecol. 12: 322-323 .
45. Jiang H. , and Hu H. 2001 . Differentiation inducing effect of bifi dobaterial surface molecules on human colonic cancer cells . Chin. J Microbiol. Immunol. 21: 186-090 .
46. Madhusudan S. , and Ganesan T.S. 2004 . Tyrosine kinase inhibitors in cancer therapy . Clin. Biochem. 37: 618-635 .
47. Wang L. , Zhu H. , and Pan L. 2003 . Infl uence of Bifi dobacterium on NF-κB and IκB in experimental large bowel carcinoma . Chin. J Pathophysiol. 19: 1062-1064 .
48. Dai J. , Wang L. , and Yang D. 2003 . Effect of bifi dobateria on MAPK and AP-1 of experimental large bowel carcinoma . Chin. J Exp. Surgery. 20: 1119-1120 .
49. Fujimori M. 2006 . Genetically engineered Bifi dobacterium as a drug delivery system therapy of metastatic breast cancer patients . Breast Cancer. 13: 27-31 .
50. Sznol M. , Lin S.L. , Bermudes D. , Zheng L.M. , and King I. 2000 . Use of preferentially replicating bacteria for the treatment of cancer . J. Clin. Invest. 10: 1027-1030 .
51. Yasui H. , and Ohwaki M. 1991 . Enhancement of immune response in Peyer's patch cells cultured with Bifi dobacterium breve . J. Dairy Sci. 74: 1187-1195 .
52. Dachs G.U. , Patterson A.V. , Firth J.D. , Ratcliffe P.J. , Townsend K.M. , Stratford I.J. , and Harris A.L. 1997 . Targeting gene expression to hypoxic tumor cells . Nat. Med. 3: 515-520 .
53. Reddy B.S. , and Rivenson A. 1993 . Inhibitory effect of Bifi dobacterium longum on colon, mammary and liver carcinogenesis induced by 2-amino-3-methylimidazo quinoline, a food mutagen . Cancer Res. 53: 3914-3918 .
54. Hu B. , Kou L. , Li C. , Zhu L.P. , Fan Y.R. , Wu Z.W. , Wang J.J. , and Xu G.X. 2009 . Bifi dobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth . Cancer Gene Ther. 16: 655-663 .
55. Zhu L.P. , Yin Y. , Xing J. , Li C. , Kou L. , Hu B. , Wu Z.W. , Wang J.J. , and Xu G.X. 2009 . Therapeutic effi cacy of Bifi dobacterium longum-mediated human granulocyte colony-stimulating factor and/or endostatin combined with cyclophosphamide in mouse-transplanted tumors . Cancer Sci. 100 ( 10 ): 1986-0990 .
56. Dang L.H. , Bettegowda C. , Huso D.L. , Kinzler K.W. , and Vogelstein B. 2001 . Combination bacteriolytic therapy for the treatment of experimental tumors . Proc. Natl. Acad. Sci. U S A. 98: 15155-15160 .
57. Slavin R.E. , Millan J.C. , and Mullins G.M. 1975 . Pathology of high dose intermittent cyclophosphamide therapy . Hum. Pathol. 6: 693-699 .
58. Cheng D.S. , Deng Y.P. , and Lu X.Y. 2000 . Effect of selenium supplementation on transplantive tumor growth and lymphocyte functions in mice . Acta Univ. Sci. Med. Chongqing. 25: 41-43 .
59. Zhao R. , Yu B.M. , and Zhang G.C. 2000 . Selenium enhancing the inhibitory effect of lymphocytes on the growth of colorectal neoplasm in nude mice . Chin. J. Exp. Surg. 17: 302-303.